Award recordCONTRACT

GRIFOLS THERAPEUTICS LLC

PIID VA26017F2969· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $179,765 net obligations· UEI UFQ3A7GKJ5C7· NC

Description

PROLASTIN FOR BOISE VA MEDICAL CENTER. THE PURPOSE OF THIS MODIFICATION IS TO REDUCE THE AWARD AMOUNT FROM $206,016.12 TO $179,764.80. THIS REDUCTION IS BASED ON ACTUAL DELIVERIES RECEIVED UNDER THIS DELIVERY ORDER FOR THE PERIOD OF PERFORMANCE OF OCTOBER 1, 2016, THROUGH SEPTEMBER 30, 2017.

Base award description: PROLASTIN

First action · last action
2016-10-01 · 2017-10-18
Transactions
2
First transaction's obligation
$206,016
Base + all options value (sum of deltas)
$179,765
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30042
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$206,016$0Base award · 2016-10-01 · this action $206,016 · running total $206,016Modification P00001 · 2017-10-18 · this action -$26,251 · running total $179,765
  • Base2016-10-01+$206,016= $206,016
  • Mod P000012017-10-18-$26,251= $179,765
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-10-01+$206,016$206,016PROLASTIN
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2017-10-18−$26,251$179,765PROLASTIN FOR BOISE VA MEDICAL CENTER. THE PURPOSE OF THIS MODIFICATION IS TO REDUCE THE AWARD AMOUNT FROM $…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI UFQ3A7GKJ5C7)

AwardOffice · PSC / listingNet obligationsFY
36C26022F0140260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$100,282FY2022
36C26022F0004260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$454,461FY2022
36C26021F0264260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$130,406FY2021
36C26021F0117260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$75,000FY2021
36C26021F0014260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$220,000FY2021
36C26021F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$355,273FY2021

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26017F2969_3600_V797D30042_3600 · retrieved 2026-09-26.